Asenbaum S[au] - Search Results

Year	Number of Results
1988	1
1989	1
1990	1
1991	3
1992	3
1993	4
1994	2
1995	7
1996	3
1997	7
1998	4
1999	5
2000	6
2001	8
2002	10
2003	5
2004	3
2005	2
2006	5
2007	5
2009	4
2010	4
2011	2
2012	5
2013	5
2014	2
2016	2
2022	0

1

[PET and SPECT investigations in Alzheimer's disease].

Asenbaum S. Asenbaum S. Radiologe. 2003 Jul;43(7):521-30. doi: 10.1007/s00117-003-0919-2. Epub 2003 Jun 25. Radiologe. 2003. PMID: 12955214 Review. German.

2

Nuclear medicine in the preoperative evaluation of epilepsy.

Asenbaum S, Baumgartner C. Asenbaum S, et al. Nucl Med Commun. 2001 Jul;22(7):835-40. doi: 10.1097/00006231-200107000-00017. Nucl Med Commun. 2001. PMID: 11453059 Review.

3

Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.

Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R. Kasper S, et al. Among authors: asenbaum s. Int Clin Psychopharmacol. 2009 May;24(3):119-25. doi: 10.1097/YIC.0b013e32832a8ec8. Int Clin Psychopharmacol. 2009. PMID: 19367152 Review.

4

SPECT and PET imaging of the dopaminergic system in Parkinson's disease.

Brücke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I. Brücke T, et al. Among authors: asenbaum s. J Neurol. 2000 Sep;247 Suppl 4:IV/2-7. doi: 10.1007/pl00007769. J Neurol. 2000. PMID: 11199811 Review.

5

EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force.

Masdeu JC, Irimia P, Asenbaum S, Bogousslavsky J, Brainin M, Chabriat H, Herholz K, Markus HS, Martínez-Vila E, Niederkorn K, Schellinger PD, Seitz RJ; EFNS. Masdeu JC, et al. Among authors: asenbaum s. Eur J Neurol. 2006 Dec;13(12):1271-83. doi: 10.1111/j.1468-1331.2006.01507.x. Eur J Neurol. 2006. PMID: 17116208 Review.

6

Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy.

Perju-Dumbrava LD, Kovacs GG, Pirker S, Jellinger K, Hoffmann M, Asenbaum S, Pirker W. Perju-Dumbrava LD, et al. Among authors: asenbaum s. Mov Disord. 2012 Jan;27(1):65-71. doi: 10.1002/mds.24000. Epub 2011 Nov 18. Mov Disord. 2012. PMID: 22102521

7

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T. Kasper S, et al. Among authors: asenbaum s. World J Biol Psychiatry. 2002 Jul;3(3):133-46. doi: 10.3109/15622970209150614. World J Biol Psychiatry. 2002. PMID: 12478878 Review.

8

Impaired olfactory function in Parkinson's disease.

Lehrner J, Brücke T, Kryspin-Exner I, Asenbaum S, Podreka I. Lehrner J, et al. Among authors: asenbaum s. Lancet. 1995 Apr 22;345(8956):1054-5. doi: 10.1016/s0140-6736(95)90797-1. Lancet. 1995. PMID: 7723526 No abstract available.

9

[Sleep disorders in neurology. Hypersomnia].

Stepansky R, Asenbaum S, Saletu B, Zeitlhofer J. Stepansky R, et al. Among authors: asenbaum s. Wien Klin Wochenschr. 1997 Nov 28;109(22):869-77. Wien Klin Wochenschr. 1997. PMID: 9476335 Review. German.

10

Dopamine receptor classification, neuroanatomical distribution and in vivo imaging.

Brücke T, Wenger S, Podreka I, Asenbaum S. Brücke T, et al. Among authors: asenbaum s. Wien Klin Wochenschr. 1991;103(21):639-46. Wien Klin Wochenschr. 1991. PMID: 1771898 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results